These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 914527)

  • 61. [Search for effective means in the early detection of breast cancer].
    Pavlov KA; Semiglazov VF; Chernomordikova MF
    Vopr Onkol; 1981; 27(8):26-9. PubMed ID: 7281589
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The abnormal mammogram in women with clinically normal breasts.
    Sterns EE
    Can J Surg; 1995 Apr; 38(2):168-72. PubMed ID: 7728672
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and screening of women at high risk of breast cancer.
    Krischer JP; Cook B; Weiner RS
    Cancer Detect Prev; 1988; 13(1):65-74. PubMed ID: 3224347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Index for rating diagnostic tests.
    YOUDEN WJ
    Cancer; 1950 Jan; 3(1):32-5. PubMed ID: 15405679
    [No Abstract]   [Full Text] [Related]  

  • 66. Periodic breast cancer screening. The first two years of screening.
    Shapiro S; Strax P; Venet L
    Arch Environ Health; 1967 Nov; 15(5):547-53. PubMed ID: 6066259
    [No Abstract]   [Full Text] [Related]  

  • 67. Lead time gained by diagnostic screening for breast cancer.
    Hutchison GB; Shapiro S
    J Natl Cancer Inst; 1968 Sep; 41(3):665-81. PubMed ID: 5677315
    [No Abstract]   [Full Text] [Related]  

  • 68. The screening of well women for the early detection of breast cancer using clinical examination with thermography and mammography.
    Stark AM; Way S
    Cancer; 1974 Jun; 33(6):1671-9. PubMed ID: 4834162
    [No Abstract]   [Full Text] [Related]  

  • 69. Lead time in breast cancer detection and implications for periodicity of screening.
    Shapiro S; Goldberg JD; Hutchison GB
    Am J Epidemiol; 1974 Nov; 100(5):357-66. PubMed ID: 4417355
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests.
    Feinstein AR
    Clin Pharmacol Ther; 1975 Jan; 17(1):104-16. PubMed ID: 1122664
    [No Abstract]   [Full Text] [Related]  

  • 71. Test sequences in screening for breast cancer.
    Siu TO; Hancock JR
    Health Serv Res; 1977; 12(3):250-68. PubMed ID: 914527
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of screening for breast cancer in older women.
    Morrison AS
    J Gerontol; 1992 Nov; 47 Spec No():80-4. PubMed ID: 1430889
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Mass screening of breast cancer].
    Dobashi K; Mori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):885-93. PubMed ID: 7594898
    [No Abstract]   [Full Text] [Related]  

  • 74. Screening for breast cancer: how effective are our tests? A critical review.
    Moskowitz M
    CA Cancer J Clin; 1983; 33(1):26-39. PubMed ID: 6401574
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.